These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 31331773

  • 1. Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6-8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study.
    Susarla SK, Gupta M, Mantan M, Dhongade R, Bhave S, Das RK, Ray RK, Ramesh Babu T, Ravi MD, Krishnamurthy B, James S, Sandhya G, Satish M, Sahoo DP.
    Vaccine; 2019 Aug 23; 37(36):5452-5459. PubMed ID: 31331773
    [Abstract] [Full Text] [Related]

  • 2. A randomized, open label trial to evaluate and compare the immunogenicity and safety of a novel liquid hexavalent DTwP-Hib/Hep B-IPV (EasySix™) to licensed combination vaccines in healthy infants.
    Mohanty L, Sharma S, Behera B, Panwar S, Paliwal C, Gupta A, Chilkoti DC, Singh A.
    Vaccine; 2018 Apr 19; 36(17):2378-2384. PubMed ID: 29580640
    [Abstract] [Full Text] [Related]

  • 3. Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants.
    Gandhi DJ, Dhaded SM, Ravi MD, Dubey AP, Kundu R, Lalwani SK, Chhatwal J, Mathew LG, Gupta M, Sharma SD, Bavdekar SB, Jayanth MV, Ravinuthala S, Sil A, Dhingra MS.
    Hum Vaccin Immunother; 2016 Apr 02; 12(4):946-54. PubMed ID: 26580093
    [Abstract] [Full Text] [Related]

  • 4. A phase III single arm, multicenter, open-label study to assess the immunogenicity and tolerability of a pentavalent DTwP-HepB-Hib vaccine in indian infants.
    Eregowda A, Lalwani S, Chatterjee S, Vakil H, Ahmed K, Costantini M, Lattanzi M.
    Hum Vaccin Immunother; 2013 Sep 02; 9(9):1903-9. PubMed ID: 23783081
    [Abstract] [Full Text] [Related]

  • 5. A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months.
    Silfverdal SA, Icardi G, Vesikari T, Flores SA, Pagnoni MF, Xu J, Liu GF, Stek JE, Boisnard F, Thomas S, Ziani E, Lee AW.
    Vaccine; 2016 Jul 19; 34(33):3810-6. PubMed ID: 27288217
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity and Safety of Three WHO Prequalified (DTwP -HB-Hib) Pentavalent Combination Vaccines Administered As Per Iranian National Immunization Plan in Iranian Infants: A Randomized, Phase III Study.
    Tabatabaei SR, Karimi A, Zahraei SM, Esteghamati A, Azimi L, Shirvani F, Mohammadi S, Rajabnejad M, Shamshiri A, Faghihian R, Faghihian E.
    Indian Pediatr; 2021 Dec 15; 58(12):1131-1135. PubMed ID: 34939580
    [Abstract] [Full Text] [Related]

  • 7. Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6 months of age.
    Wanlapakorn N, Pruetarat N, Sarawanangkoor N, Phanphanit K, Srimuan D, Thatsanathorn T, Thongmee T, Posuwan N, Poovorawan Y.
    Vaccine; 2023 Jun 13; 41(26):3855-3861. PubMed ID: 37202270
    [Abstract] [Full Text] [Related]

  • 8. A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants.
    Mohanty L, Sharma S, Behera B, Panwar S, Paliwal C, Singh A, Gupta A, Chilkoti DC.
    Hum Vaccin Immunother; 2017 Sep 02; 13(9):2025-2031. PubMed ID: 28700282
    [Abstract] [Full Text] [Related]

  • 9. Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process.
    Sharma HJ, Patil VD, Lalwani SK, Manglani MV, Ravichandran L, Kapre SV, Jadhav SS, Parekh SS, Ashtagi G, Malshe N, Palkar S, Wade M, Arunprasath TK, Kumar D, Shewale SD.
    Vaccine; 2012 Jan 11; 30(3):510-6. PubMed ID: 22119927
    [Abstract] [Full Text] [Related]

  • 10. Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants-A randomized study.
    Aloysia D'Cor N, Siddaiah P, Mohapatra S, Dhaded SM, I V P, Kar S, V N T, Muley P, Chhatwal J, Patnaik BN, Vidor E, Moureau A, Patel DM, Midde VJ, Jagga SR, Peesapati S, Noriega F.
    PLoS One; 2023 Jan 11; 18(8):e0284898. PubMed ID: 37582114
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the immunogenicity and safety of pentavalent vaccine Quinvaxem in a compact prefilled auto-disabled (cPAD) injection system versus single-dose vials in healthy infants: a phase 3, open-label, randomized, parallel-group, non-inferiority study.
    Capeding MR, Alberto E, Versteilen A, Rauscher M, Bagchi P, Palacios PI.
    Int J Infect Dis; 2016 May 11; 46():71-8. PubMed ID: 26923083
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study.
    Kim KH, Kim CS, Kim HM, Kim JD, Ma SH, Kim DH, Hwang PH, Han JW, Lee TJ, Kim JH, Karkada N, Mesaros N, Sohn WY, Kim JH.
    Hum Vaccin Immunother; 2019 May 11; 15(2):317-326. PubMed ID: 30431387
    [Abstract] [Full Text] [Related]

  • 13. Antibody persistence of two pentavalent DTwP-HB-Hib vaccines to the age of 15-18 months, and response to the booster dose of quadrivalent DTwP-Hib vaccine.
    Sharma H, Yadav S, Lalwani S, Kapre S, Jadhav S, Parekh S, Palkar S, Ravetkar S, Bahl S, Kumar R, Shewale S.
    Vaccine; 2013 Jan 07; 31(3):444-7. PubMed ID: 23196204
    [Abstract] [Full Text] [Related]

  • 14. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S.
    BioDrugs; 2010 Oct 01; 24(5):299-302. PubMed ID: 20795752
    [Abstract] [Full Text] [Related]

  • 15. A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16-24 months.
    Sharma H, Lalwani S, Parekh S, Pujari P, Shewale S, Palkar S, Hanumante N, Gokhale S, Ks J, Kumar R, Sharma I, Gairola S.
    Hum Vaccin Immunother; 2022 Nov 30; 18(6):2146435. PubMed ID: 36412272
    [Abstract] [Full Text] [Related]

  • 16. Interchangeability of Quinvaxem during primary vaccination schedules: results from a phase IV, single-blind, randomized, controlled, single-center, non-inferiority study.
    Capeding MR, Jica C, Macura-Biegun A, Rauscher M, Alberto E.
    Vaccine; 2014 Feb 07; 32(7):888-94. PubMed ID: 24176498
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children.
    Sharma HJ, Yadav S, Lalwani SK, Kapre SV, Jadhav SS, Chakravarty A, Parekh SS, Palkar S, Bhardwaj SH, Namjoshi GS, Verma V.
    Hum Vaccin; 2011 Apr 07; 7(4):451-7. PubMed ID: 21403463
    [Abstract] [Full Text] [Related]

  • 18. DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18-24 months old.
    Gunardi H, Rusmil K, Fadlyana E, Soedjatmiko, Dhamayanti M, Sekartini R, Tarigan R, Satari HI, Medise BE, Sari RM, Bachtiar NS, Kartasasmita CB, Hadinegoro SRS.
    BMC Pediatr; 2018 May 28; 18(1):177. PubMed ID: 29804542
    [Abstract] [Full Text] [Related]

  • 19. Safety and immunogenicity of Haemophilus influenzae type B vaccine given in combination with DTwP at 6, 10 and 14 weeks of age.
    Cherian T, Thomas N, Raghupathy P, Durot I, Dutta A.
    Indian Pediatr; 2002 May 28; 39(5):427-36. PubMed ID: 12037271
    [Abstract] [Full Text] [Related]

  • 20. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
    Saluja T, Palkar S, Misra P, Gupta M, Venugopal P, Sood AK, Dhati RM, Shetty A, Dhaded SM, Agarkhedkar S, Choudhury A, Kumar R, Balasubramanian S, Babji S, Adhikary L, Dupuy M, Chadha SM, Desai F, Kukian D, Patnaik BN, Dhingra MS.
    Vaccine; 2017 Jun 16; 35(28):3575-3581. PubMed ID: 28536027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.